Legal challenge denied

UK pharma denied legal challenge to drugs bill cap – updated


ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.

Read the full article here

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.